Warning Letter Roundup & Recap
This article was originally published in The Silver Sheet
Executive Summary
CAPA procedures weren’t established and maintained at device-makers Smith & Nephew, GaleMed and MedMizer; CareFusion’s spec developer/complaint handler didn’t investigate complaints or implement MDR procedures. Eight quality-related warning letters were listed by FDA from July 8 through Aug. 11.